GlassScriptPhysician profile
Shanti Eppanapally
NPI 1306872635
$2,351.90
in general payments reported to CMS, 2019-2025
26 companies · $377 in 2025
The $377 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $196 · 2021: $311 · 2022: $570 · 2023: $412 · 2024: $191 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $979.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $455.67 | 2022-2023 | Proclaim |
| Collegium Pharmaceutical, INC. | $344.16 | 2020-2025 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $278.14 | 2019-2023 | Xifaxan, Plenvu |
| Redhill Biopharma INC. | $153.13 | 2020-2022 | |
| Si-Bone, INC. | $141.30 | 2019 | |
| Glaxosmithkline, LLC. | $129.86 | 2022-2025 | Trelegy Ellipta, Arexvy |
| Biotronik Nro, INC. | $125.66 | 2025 | Prospera |
| Heron Therapeutics, INC. | $115.19 | 2025 | Aponvie |
| Takeda Pharmaceuticals U.S.A., INC. | $108.85 | 2020-2022 | |
| Nalu Medical, INC. | $90.63 | 2022 | |
| Vertos Medical, INC. | $63.92 | 2022 | |
| Biodelivery Sciences International, INC. | $52.13 | 2020-2021 | |
| Abbvie INC. | $49.29 | 2020-2022 | |
| Boston Scientific Corporation | $43.36 | 2022 | |
| Electronic Waveform Lab, INC. | $37.64 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $20.86 | 2022 | |
| Globus Medical, INC. | $20.53 | 2025 | Senza |
| Nestle Healthcare Nutrition INC. | $15.00 | 2021 | |
| Allergan, INC. | $14.94 | 2020 | |
| Braintree Laboratories, INC. | $14.14 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.13 | 2021 | |
| Intercept Pharmaceuticals, INC. | $13.60 | 2020 | |
| Kaleo, INC. | $12.79 | 2022 | |
| Merck Sharp & Dohme LLC | $12.50 | 2019 | |
| Mannkind Corporation | $12.39 | 2021 | |
| Horizon Therapeutics Plc | $12.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shanti Eppanapally listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.